Treatment strategy for chronic rhinosinusitis

First-line and second-line treatments for chronic sinusitis. Often patients with chronic rhinosinusitis ask about their first-line treatment options and experts in the field can consider then a couple of options that could alleviate the symptoms in the majority of these patients.

Prof. Peter Hellings, Founder of EUFOREA, suggests the use of nasal douching with saline as one of the first treatment options that patients could consider when they have chronic rhinosinusitis. Nasal douching saline means that patients are advised twice a day to rinse the nasal cavity with a saline solution allowing them to rinse away all the pro-inflammatory triggers that are responsible for the disease development.

Watch now this interview and discover what other recommendations Prof. Peter Hellings provides as a treatment strategy to any patient who suffers from chronic rhinosinusitis.

Stay in touch for further news from EUFOREA!

FOR HEALTHCARE PROVIDERS: Download the Chronic Rhinosinusitis Pocket Guide & Treatment Algorithm (in English, Spanish, Dutch, and French) here!

​
📌 EUFOREA is an international non-profit organization forming an alliance of all stakeholders dedicated to reduce the prevalence and burden of allergies and airway diseases through the implementation of optimal patient care through education, research and advocacy.
--------------------------------------------------------------------------------------------------------------------------
Subscribe to our YouTube Channel for our latest videos within Allergies and Airway Diseases
--------------------------------------------------------------------------------------------------------------------------
Get in touch with EUFOREA team for any questions

#EUFOREA

[aryanasmith]

I like your video presentation. It is informative too, at the same time. Thanks a lot for your guidance!

[falloutman]

Doctor, a couple of doctors I saw said chronic sinusitis generally resolves in most patients within 4 t 6 months. This being said, there is a risk of redeveloping it in a 2 year window. They said there are some who suffer for years on end but these patients are generally rare. Are they correct?